Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma [8]

Niels W.C.J. Van De Donk, Nicolaus Kröger, Ute Hegenbart, Paolo Corradini, Jesus F. San Miguel, Hartmut Goldschmidt, Jose A. Perez-Simon, Mark Zijlmans, Reinier A. Raymakers, Vittorio Montefusco, Francis A. Ayuk, Marinus H.J. Van Oers, Arnon Nagler, Leo F. Verdonck, Henk M. Lokhorst

    Research output: Contribution to journalLetter

    66 Scopus citations
    Original languageEnglish (US)
    Pages (from-to)3415-3416
    Number of pages2
    JournalBlood
    Volume107
    Issue number8
    DOIs
    StatePublished - Apr 15 2006

    ASJC Scopus subject areas

    • Biochemistry
    • Immunology
    • Hematology
    • Cell Biology

    Cite this

    Van De Donk, N. W. C. J., Kröger, N., Hegenbart, U., Corradini, P., San Miguel, J. F., Goldschmidt, H., Perez-Simon, J. A., Zijlmans, M., Raymakers, R. A., Montefusco, V., Ayuk, F. A., Van Oers, M. H. J., Nagler, A., Verdonck, L. F., & Lokhorst, H. M. (2006). Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma [8]. Blood, 107(8), 3415-3416. https://doi.org/10.1182/blood-2005-11-4449